Last reviewed · How we verify
NCT05640661
Effects of Terminal Visual Feedback Therapy After Immersive Virtual Reality in Patients With Chronic Shoulder Pain
NA trial testing Oculus Quest II in Shoulder Pain in 24 participants. Status unknown.
3 July 2024
Quick facts
| Lead sponsor | University of Malaga |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 4 December 2023 |
| Primary completion | 3 July 2024 |
| Estimated completion | 3 July 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Oculus Quest II
- Oculus Quest II
Conditions studied
- Shoulder Pain — all drugs for Shoulder Pain →
- Movement Disorders — all drugs for Movement Disorders →
Sponsor
University of Malaga
Who can join
Adults 18 to 65, any sex, with Shoulder Pain or Movement Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is effect of terminal visual feedback therapy following the use of immersive virtual reality(VRi) effects on pain,kinesiophobia, fear of pain, disability, self-efficacy, grip strength and range of motion in motion in people with chronic shoulder pain compare with just VRi. The main question\[s\] it aims to answer are: * Can terminal visual feedback therapy following the use of immersive virtual reality software decrease movement-evoked pain in patients with chronic shoulder pain compared with just VRi? * Can terminal visual feedback therapy following the use of immersive virtual reality software increase shoulder flexion range of motion in patients with chronic shoulder pain compared with just VRi? Participants will use a visual feedback therapy following the use of immersive virtual reality software compared with just specific VRi software
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05640661
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Shoulder Pain
Currently open trials in the same condition.
- NCT07493226 — Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis · NA · recruiting
- NCT07493213 — USG-Guided Shoulder Injections in Frozen Shoulder · NA · recruiting
- NCT07424638 — Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain · NA · recruiting
- NCT07394673 — Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Analgesia in Arthroscopic Shoulder Surgery · NA · recruiting
- NCT07334171 — Inspiratory Muscle Strength and Diaphragm Thickness in People With Shoulder Pain in Tennis Players · active not recruiting
Other University of Malaga trials
Trials by the same sponsor.
- NCT07472205 — Foot and Ankle Strengthening Program to Improve Physical Function in Menopausal Women · NA · not yet recruiting
- NCT07408622 — Virtual Reality Therapy for Wrist and Hand Injury Recovery · NA · not yet recruiting
- NCT07428304 — Cortical Changes After Upper Limb Immobilization Measured by Electroencephalography · not yet recruiting
- NCT07371715 — Home-Based Auricular Transcutaneous Vagus Nerve Stimulation (tVNS) for Sleep Quality and Psycho-Academic Outcomes in Hea · NA · not yet recruiting
- NCT06438666 — Effects Obtained at Manual Function After Applying Anodic Transcranial Direct Current Stimulation (tCDS) in Children Wit · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05640661 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Malaga
- Last refreshed: 12 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05640661.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing